Oncolytics Biotech Inc T.ONC

H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech

[spesestsemper]

H.C. Wainwright Reiterates Buy Rating on Oncolytics Biotech (ONCY) (streetinsider.com)

[laroplex]

Total disconnect from our measly s/pm it's a freaking joke.....Big Pharma keeping lid on us....Here's the average analyst price target....GLTA Oncolytics Biotech (NASDAQ:ONCY) Stock, Analyst Ratings, Price Targets, Forecasts Oncolytics Biotech Inc has a consensus price target of $5 based on the ratings of 5 analysts. The high is $9 issued by 

[venture009]

Unfortunately over the years none of these analysts have been correct. The last years BT was running ONC he seemed to have pivoted to getting approval in Europe versus with the FDA. Because of BP influence over the FDA I believe they should have continued with this strategy.  I am highly suspicious of the FDA overall intentions when it comes to drug approvals.

[spesestsemper]

Analysts As it shows up in my account. In US funds - please do your own due diligence Patrick Trucchio - H C Wainwright - 0 out of 5 star rating  $5.00 Buy maintained 8/21/24 John Newman - Canaccord Genuity - 31/2 stars out of 5 rating $5.00 Buy maintained 8/12/24 Soumit Roy - Jones Trading - 0 out of 5 star rating - $6.61 Buy maintained 8/1/24 Douglas Miehm - RBC capital - 1 out of 5

[spesestsemper]

Oncolytics Biotech conserve son objectif de prix et sa note d'achat par H.C. Wainwright Par Investing.com (fr-investing-com.translate.goog) HC Wainwright maintained a Buy rating with a $5.00 price target on Oncolytics Biotech (NASDAQ:ONCY). The firm's position follows a recent non-commercial roadshow by Oncolytics' management team, which highlighted the company's lead program

[CMHarring218431]

Why doesn't Oncy put out this easy to read, plain English, fine tuned article that explains the objectives concisely. "Their targeted approach to breast and pancreatic cancer is expected to generate significant value in the NEAR TERM." Let's get started on or front by highlighting this analysis. 

[CMHarring218431]

Should read let's get started on the pr front by highlighting this analysis.